复发性前列腺癌患者PSMA PET/CT显示播散性表皮样囊肿摄取PSMA配体
一名71岁根治性前列腺切除术后生化复发的前列腺癌患者接受PSMA配体PET/CT检查,除1枚淋巴结见 intense 摄取疑为转移外,还见播散性PSMA配体摄取增高的皮下病灶,其中1个病灶组织病理学证实为表皮样囊肿。医师应认识到PSMA配体摄取增高的非前列腺癌原因,本病例即为一例。
要点
- 前列腺癌生化复发患者PSMA PET/CT可见播散性皮下病灶摄取PSMA配体。
- 其中1个皮下病灶组织病理学证实为表皮样囊肿。
- 医师应知晓PSMA配体摄取增高的非前列腺癌原因。
核心结论
- 播散性表皮样囊肿可表现为PSMA配体摄取增高,是前列腺癌之外的原因之一。
研究设计与样本
- 病例报告:1例71岁根治性前列腺切除术后生化复发的前列腺癌患者接受PSMA配体PET/CT检查。
主要发现
- PSMA配体PET/CT见1枚淋巴结呈 intense PSMA配体摄取,疑为转移。
- 同时见播散性PSMA配体摄取增高的皮下病灶。
- 其中1个皮下病灶组织病理学检查示表皮样囊肿。
临床怎么用
- 原文结论指出医师应保持对PSMA配体摄取增高的非前列腺癌原因的认识。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PSMA PET/CT is routinely used for the detection of prostate cancer (PC). However, increased PSMA-ligand uptake has been described in a variety of benign and malignant tissues. A 71-year-old man with biochemical recurrence of PC initially treated with radical prostatectomy was referred for PSMA-ligand PET/CT. Apart from 1 lymph node with intense PSMA-ligand uptake, suspicious for metastasis, disseminated PSMA-ligand-avid subcutaneous lesions were seen. Histopathology of 1 of these lesions revealed an epidermoid cyst. Physicians should remain cognizant of non-PC-related causes of increased PSMA-ligand uptake, of which this case represent yet another example.
引用
- Bohn KP, Alberts I, Mingels C, et al. PSMA-Ligand Uptake in Disseminated Epidermoid Cysts in a PSMA PET/CT of a Patient With Recurrent Prostate Cancer. Clin Nucl Med. 2021. PMID: 34735414. doi:10.1097/RLU.0000000000003749
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。